Active substances
Polyethylene glycol + Potassium chloride + Sodium bicarbonate + Sodium chloride
- SFDA 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LAXO | 350.7,178.5,46.6,13.125 mg,mg,mg,g | Granules · Oral use | 20 Sachet | SAR 30.00 | Generic · Prescription | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
Indications — CHI Daman Drug Formulary
ANAL FISSURE; CONSTIPATION; HEMORRHOIDS; IRRITABLE BOWEL SYNDROME
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.